BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3078832)

  • 1. Recombinant DNA technology and enterotoxigenic Escherichia coli vaccines.
    Gyles CL; Maas WK
    Prog Vet Microbiol Immunol; 1987; 3():139-58. PubMed ID: 3078832
    [No Abstract]   [Full Text] [Related]  

  • 2. Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli.
    Lasaro MO; Luiz WB; Sbrogio-Almeida ME; Ferreira LC
    Vaccine; 2005 Mar; 23(19):2430-8. PubMed ID: 15752829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine development against enterotoxigenic Escherichia coli.
    Myers LL
    Prog Vet Microbiol Immunol; 1986; 2():145-57. PubMed ID: 3078647
    [No Abstract]   [Full Text] [Related]  

  • 4. Escherichia coli originated from diarrhea of suckling piglets in Taiwan. V. Immunization for Escherichia coli diarrhea of suckling piglets.
    Chen C; Kume T; Hiruma M; Tsubaki S; Ando K; Sasahara J
    Kitasato Arch Exp Med; 1984 Dec; 57(4):253-65. PubMed ID: 6399724
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of vaccines for bacterial diseases using recombinant DNA technology.
    Isaacson RE
    Avian Dis; 1986; 30(1):28-36. PubMed ID: 3524542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral vaccines against cholera and enterotoxigenic Escherichia coli diarrhea.
    Svennerholm AM; Holmgren J
    Adv Exp Med Biol; 1995; 371B():1623-8. PubMed ID: 7502870
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccines to prevent travelers' diarrhea.
    Levine MM
    Ther Umsch; 1983 Mar; 40(3):253-6. PubMed ID: 6344308
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral immunization of mice with plant-derived fimbrial adhesin FaeG induces systemic and mucosal K88ad enterotoxigenic Escherichia coli-specific immune responses.
    Liang W; Huang Y; Yang X; Zhou Z; Pan A; Qian B; Huang C; Chen J; Zhang D
    FEMS Immunol Med Microbiol; 2006 Apr; 46(3):393-9. PubMed ID: 16553813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prospects for the development of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (3)].
    Cravioto A
    Bol Med Hosp Infant Mex; 1984 May; 41(5):253-61. PubMed ID: 6147148
    [No Abstract]   [Full Text] [Related]  

  • 10. Delivery of heterologous protein antigens via hemolysin or autotransporter systems by an attenuated ler mutant of rabbit enteropathogenic Escherichia coli.
    Zhu C; Ruiz-Perez F; Yang Z; Mao Y; Hackethal VL; Greco KM; Choy W; Davis K; Butterton JR; Boedeker EC
    Vaccine; 2006 May; 24(18):3821-31. PubMed ID: 16098637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of calf scours with colostrum.
    Gregory DW; Nervig RM
    Mod Vet Pract; 1984 Feb; 65(2):118, 120. PubMed ID: 6374424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospects for the production of an anti-adhesive vaccine against strains of Escherichia coli causing diarrhea in humans (1)].
    Cravioto A
    Bol Med Hosp Infant Mex; 1984 Mar; 41(3):122-8. PubMed ID: 6144315
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.
    Tobias J; Lebens M; Bölin I; Wiklund G; Svennerholm AM
    Vaccine; 2008 Feb; 26(6):743-52. PubMed ID: 18191006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Scatologic aspects of Escherichia coli.
    Gorbach SL
    N Engl J Med; 1974 Jul; 291(3):150-1. PubMed ID: 4600681
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oral vaccination of piglets against coli enterotoxemia using streptomycin-dependent revertant of Escherichia coli].
    Bertschinger HU; Jucker H; Pfirter HP
    Schweiz Arch Tierheilkd; 1984 Oct; 126(10):497-509. PubMed ID: 6390674
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenicity of the ribosomal vaccine extracted from Escherichia coli.
    Dima VF; Radu J; Persu A; Munţiu V; Palade R; Petcovici M; Dragomirescu E; Coman R
    Arch Roum Pathol Exp Microbiol; 1984; 43(2):127-36. PubMed ID: 6398688
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans.
    Turner AK; Terry TD; Sack DA; Londoño-Arcila P; Darsley MJ
    Infect Immun; 2001 Aug; 69(8):4969-79. PubMed ID: 11447175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.